Xu Na, Wang Mengzhao, Zhu Zhaohui, Zhang Yingqiang, Jiao Yang, Fang Weigang
Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Chin Med J (Engl). 2014;127(4):607-13.
Integrated positron emission tomography and computed tomography (PET/CT) is increasingly used for the preoperative nodal staging of non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the accuracy of PET/CT in comparison with CT in detection of nodal metastasis and preoperative nodal staging in patients with NSCLC, and to analyze the causes of the PET/CT false-negative and false-positive results.
Consecutive patients with pathologically proven NSCLC who underwent staging using PET/CT from July 2008 to February 2012 were evaluated retrospectively. Nodal staging was pathologically confirmed on tissue specimens obtained at thoracotomy. The accuracy of PET/CT and CT in the assessment of intrathoracic nodal involvement was determined using histological results as the reference standard. Logistic regression was used to define the causes of the false-negative and false-positive results.
A total of 528 lymph node stations were evaluated in 101 patients. Lymph nodes were positive for malignancy in 43 out of 101 patients (42.6%), and 101 out of 528 nodal stations (19.2%). PET/CT was significantly more accurate for nodal staging than CT. The sensitivity, specificity, positive and negative predictive values, and accuracy of PET/CT for detecting nodal metastasis were 51.5%, 95.8%, 74.3%, 89.3%, and 87.3% and the corresponding data by CT were 45.5%, 87.1%, 45.5%, 87.1%, and 79.2%, respectively. PET/CT confers significantly higher specificity, positive predictive value, and accuracy than CT in detecting nodal metastasis. False-negative results by PET/CT are significantly associated with smaller lymph node size, whereas false-positive results are related to a combination of inflammatory disorders and larger lymph node size.
PET/CT confers significantly higher accuracy than CT in nodal staging, and is more specific and accurate than CT in detecting nodal metastasis but has a low sensitivity and high false-negative rate.
正电子发射断层扫描与计算机断层扫描(PET/CT)越来越多地用于非小细胞肺癌(NSCLC)的术前淋巴结分期。本研究的目的是评估PET/CT与CT相比在检测NSCLC患者淋巴结转移及术前淋巴结分期方面的准确性,并分析PET/CT假阴性和假阳性结果的原因。
回顾性评估2008年7月至2012年2月期间连续接受PET/CT分期的经病理证实的NSCLC患者。通过开胸手术获取的组织标本对淋巴结分期进行病理确认。以组织学结果作为参考标准,确定PET/CT和CT评估胸内淋巴结受累情况的准确性。采用逻辑回归分析来确定假阴性和假阳性结果的原因。
对101例患者的528个淋巴结站进行了评估。101例患者中有43例(42.6%)的淋巴结存在恶性病变,528个淋巴结站中有101个(19.2%)存在恶性病变。PET/CT在淋巴结分期方面的准确性明显高于CT。PET/CT检测淋巴结转移的敏感性、特异性、阳性和阴性预测值及准确性分别为51.5%、95.8%、74.3%、89.3%和87.3%,而CT的相应数据分别为45.5%、87.1%、45.5%、87.1%和79.2%。在检测淋巴结转移方面,PET/CT的特异性、阳性预测值和准确性明显高于CT。PET/CT的假阴性结果与较小的淋巴结大小显著相关,而假阳性结果与炎症性疾病和较大的淋巴结大小有关。
PET/CT在淋巴结分期方面的准确性明显高于CT,在检测淋巴结转移方面比CT更具特异性和准确性,但敏感性较低且假阴性率较高。